SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Molina Healthcare, Inc. – ‘10-Q’ for 6/30/20 – ‘R29’

On:  Friday, 7/31/20, at 10:00am ET   ·   For:  6/30/20   ·   Accession #:  1179929-20-111   ·   File #:  1-31719

Previous ‘10-Q’:  ‘10-Q’ on 5/1/20 for 3/31/20   ·   Next:  ‘10-Q’ on 10/29/20 for 9/30/20   ·   Latest:  ‘10-Q’ on 4/25/24 for 3/31/24

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 7/31/20  Molina Healthcare, Inc.           10-Q        6/30/20   65:8.9M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    896K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     23K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     23K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     20K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     20K 
12: R1          Cover Page                                          HTML     71K 
13: R2          Consolidated Statements of Income                   HTML     92K 
14: R3          Consolidated Statements of Comprehensive Income     HTML     41K 
15: R4          Consolidated Balance Sheets                         HTML     99K 
16: R5          Consolidated Balance Sheets (Parenthetical)         HTML     33K 
17: R6          Consolidated Statements of Stockholders' Equity     HTML     80K 
18: R7          Consolidated Statements of Cash Flows               HTML    115K 
19: R8          Organization and Basis of Presentation              HTML     35K 
20: R9          Significant Accounting Policies                     HTML    116K 
21: R10         Net Income per Share                                HTML     64K 
22: R11         Fair Value Measurements                             HTML    146K 
23: R12         Investments                                         HTML    158K 
24: R13         Medical Claims and Benefits Payable                 HTML     54K 
25: R14         Debt                                                HTML     51K 
26: R15         Stockholders' Equity                                HTML     59K 
27: R16         Segments                                            HTML     75K 
28: R17         Commitments and Contingencies                       HTML     23K 
29: R18         Significant Accounting Policies (Policies)          HTML     98K 
30: R19         Significant Accounting Policies (Tables)            HTML    107K 
31: R20         Net Income per Share (Tables)                       HTML     64K 
32: R21         Fair Value Measurements (Tables)                    HTML    147K 
33: R22         Investments (Tables)                                HTML    157K 
34: R23         Medical Claims and Benefits Payable (Tables)        HTML     55K 
35: R24         Debt (Tables)                                       HTML     44K 
36: R25         Stockholders' Equity (Tables)                       HTML     54K 
37: R26         Segments (Tables)                                   HTML     71K 
38: R27         Organization and Basis of Presentation (Details)    HTML     48K 
39: R28         Significant Accounting Policies - Cash and Cash     HTML     28K 
                Equivalents (Details)                                            
40: R29         Significant Accounting Policies - Narrative         HTML     47K 
                (Details)                                                        
41: R30         Significant Accounting Policies - Amounts Due To    HTML     38K 
                Government Agencies (Details)                                    
42: R31         Significant Accounting Policies - Quality           HTML     37K 
                Incentive Premium Revenue Recognized (Details)                   
43: R32         Significant Accounting Policies - Receivables       HTML     31K 
                (Details)                                                        
44: R33         Net Income per Share (Details)                      HTML     63K 
45: R34         Fair Value Measurements - Fair Value of Financial   HTML     97K 
                Instruments on Recurring Basis (Details)                         
46: R35         Fair Value Measurements - Balance Sheet Grouping    HTML     30K 
                (Details)                                                        
47: R36         Fair Value Measurements - Details of Long-Term      HTML     70K 
                Debt (Details)                                                   
48: R37         Investments - Summary of Investments (Details)      HTML     54K 
49: R38         Investments - Contractual Maturities of             HTML     47K 
                Available-for-Sale Investments (Details)                         
50: R39         Investments - Narrative (Details)                   HTML     28K 
51: R40         Investments - Available-for-Sale Investments        HTML     49K 
                (Details)                                                        
52: R41         Medical Claims and Benefits Payable - Medical       HTML     28K 
                Claims and Benefits Payable (Details)                            
53: R42         Medical Claims and Benefits Payable - Narrative     HTML     22K 
                (Details)                                                        
54: R43         Medical Claims and Benefits Payable - Components    HTML     40K 
                of Change in Medical Claims and Benefits Payable                 
                (Details)                                                        
55: R44         Debt - Schedule of Long-Term Debt (Details)         HTML     53K 
56: R45         Debt - Narrative (Details)                          HTML     79K 
57: R46         Stockholders' Equity - Narrative (Details)          HTML     66K 
58: R47         Stockholders' Equity - Share Activity (Details)     HTML     48K 
59: R48         Stockholders' Equity - Fair Value of Awards         HTML     28K 
                Granted and Vested (Details)                                     
60: R49         Segments - Narrative (Details)                      HTML     20K 
61: R50         Segments - Reconciliation of Gross Margin to        HTML     49K 
                Consolidated Income (Details)                                    
63: XML         IDEA XML File -- Filing Summary                      XML    112K 
11: XML         XBRL Instance -- moh-20200630_htm                    XML   2.40M 
62: EXCEL       IDEA Workbook of Financial Reports                  XLSX     83K 
 7: EX-101.CAL  XBRL Calculations -- moh-20200630_cal                XML    210K 
 8: EX-101.DEF  XBRL Definitions -- moh-20200630_def                 XML    464K 
 9: EX-101.LAB  XBRL Labels -- moh-20200630_lab                      XML   1.37M 
10: EX-101.PRE  XBRL Presentations -- moh-20200630_pre               XML    794K 
 6: EX-101.SCH  XBRL Schema -- moh-20200630                          XSD    140K 
64: JSON        XBRL Instance as JSON Data -- MetaLinks              328±   478K 
65: ZIP         XBRL Zipped Folder -- 0001179929-20-000111-xbrl      Zip    293K

‘R29’   —   Significant Accounting Policies – Narrative (Details)

This is an IDEA Financial Report.  [ Alternative Formats ]

 
v3.20.2
Significant Accounting Policies - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Schedule of Premium Revenue by Health Plan Type [Line Items]          
Maturity period     10 years    
Average maturity period     10 years    
Interest receivable   $ 10.0 $ 10.0   $ 12.0
Risk adjustment payable   529.0 529.0   (368.0)
Risk adjustment receivable   72.0 72.0   63.0
Risk adjustment, net payable   457.0 457.0   $ 305.0
Risk adjustment, net payable, current year   (160.0) (160.0)    
Risk adjustment, net payable, prior year   297.0 297.0    
HIF liabilities   277.0 277.0 $ 271.0  
Increase in HIF liabilities     $ 6.0    
Maine Community Health Options v. United States          
Schedule of Premium Revenue by Health Plan Type [Line Items]          
Summary judgement $ 128.1        
COVID-19          
Schedule of Premium Revenue by Health Plan Type [Line Items]          
Reduction in premiums   $ 75.0      

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:7/31/20
For Period end:6/30/204
6/18/20
1/1/204
12/31/1910-K
 List all Filings 
↑Top
Filing Submission 0001179929-20-000111   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Wed., May 15, 7:49:55.1pm ET